The human genome contains approximately 1,600 types of transcription factors responsible for regulating gene activity across ...
Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...
An in vivo chimeric antigen receptor T-cell therapy administered without lymphodepletion exhibited activity among patients with advanced multiple myeloma, according to findings presented at ASH Annual ...
The company intends to file a U.S. application in the first half of 2026 following positive study results in a condition ...
The field of immunology of ageing is rapidly evolving, with T cells playing a pivotal role in maintaining immune competence and overall organismal ...
Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...
On track to file a Clinical Trial Application (CTA) by year end 2025, with initial clinical data expected mid-2026Important ...
This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...
Inaugural Members of the Akadeum CDMO Alliance: ElevateBio (R) and Charles River. Akadeum has collaborated with both CDMOs, establishing strong data sets demonstrating reduced impurities and high ...
From microglia reprogramming to immune cell-based diagnostics, 2025 was a big year for breakthroughs in cell biology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback